Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Passive investing works because low costs, broad market exposure, and compounding drive steady growth. This piece explains the logic and practical steps.
20,348 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A Jordan base attack left two U.S. service members dead and one missing as tensions flare with Iran. The fallout hits...
Meta Platforms stock has moved lower—about 17% over six months. This article breaks down what that decline means, how...
As investors weigh potential Fed easing, the EDV ETF could surge on falling long-term yields. Here's what to know abo...
In March 2026, smart japan investors choosing hedged exposure via DXJ are gaining ground as currency moves and reform...
A seasoned market watcher outlines a bold bull case for Bitcoin and Ethereum, suggesting cryptocurrencies poised soar...
PennyMac’s Third-Party Origination unit rolls out a seven-program non-QM suite to broaden options for borrowers with ...
A federal judge paused the $81 billion Paramount-Warner merger for two weeks as 12 states challenge the deal over com...
Cloudflare is riding an 11% weekly rally fueled by Reddit optimism. But with a sky-high forward earnings multiple and...
The Digital Chamber filed a lawsuit against Illinois over a 0.2% tax on digital asset transactions, arguing the levy ...
March 2026 sees a surge in MetaStock alternatives as traders seek real-time data, AI insights, and cloud-based tools....
Dividend income investors watch yields closely. This article explains how yields move, why this dividend ETF's yield ...